BOSTON SCIENTIFIC CORP (BSX)
Every FINRA and SEC series the site collects for BOSTON SCIENTIFIC CORP: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on NYSE, classified by the SEC as surgical & medical instruments & apparatus.
48.2M
Short interest
settlement 2026-08-31
2.3
Days to cover
+74.4% vs prior
42.9%
Short share of volume
2026-09-17
3,497
Fails to deliver
settlement 2026-08-24
Wed 21 Oct
Next earnings
estimated; last year 2025-10-22
$9.5M
Insider flow, 90 days
6 buys, 0 sells
As of 2026-09-17.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in BSX is 48,173,758 shares, up 25,897,557 shares over the last month. Over the last 48 readings it ranged from 10,449,826 shares (31 January 2025) to 57,491,117 shares (29 May 2026). At the reported average volume of 21.0M shares a day that is 2.3 days to cover.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/bsx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 48,173,758 | +74.4% | 21,036,931 | 2.29 |
| 2026-08-14 | 27,617,554 | +24.0% | 17,642,161 | 1.57 |
| 2026-07-31 | 22,276,201 | -21.2% | 21,974,600 | 1.01 |
| 2026-07-15 | 28,281,040 | +1.2% | 16,776,824 | 1.69 |
| 2026-06-30 | 27,938,624 | -6.1% | 23,398,673 | 1.19 |
| 2026-06-15 | 29,750,309 | -48.3% | 20,617,498 | 1.44 |
| 2026-05-29 | 57,491,117 | +83.0% | 25,507,630 | 2.25 |
| 2026-05-15 | 31,423,298 | +9.7% | 17,713,835 | 1.77 |
| 2026-04-30 | 28,642,737 | +11.8% | 21,126,230 | 1.36 |
| 2026-04-15 | 25,614,558 | +8.9% | 14,196,053 | 1.80 |
| 2026-03-31 | 23,529,218 | -7.5% | 16,507,632 | 1.43 |
| 2026-03-13 | 25,441,563 | -3.1% | 12,874,974 | 1.98 |
| 2026-02-27 | 26,261,043 | -1.4% | 13,520,963 | 1.94 |
| 2026-02-13 | 26,641,433 | -5.8% | 27,986,053 | 1.00 |
| 2026-01-30 | 28,281,105 | +20.8% | 14,359,024 | 1.97 |
| 2026-01-15 | 23,415,429 | +17.0% | 10,294,612 | 2.27 |
| 2025-12-31 | 20,010,940 | +4.5% | 8,454,112 | 2.37 |
| 2025-12-15 | 19,144,680 | +2.2% | 10,117,284 | 1.89 |
| 2025-11-28 | 18,734,072 | -11.1% | 9,892,043 | 1.89 |
| 2025-11-14 | 21,076,004 | +8.3% | 7,709,891 | 2.73 |
| 2025-10-31 | 19,453,503 | -0.9% | 8,516,401 | 2.28 |
| 2025-10-15 | 19,634,328 | +1.2% | 9,665,641 | 2.03 |
| 2025-09-30 | 19,401,596 | +2.0% | 13,301,110 | 1.46 |
| 2025-09-15 | 19,015,043 | +0.1% | 8,063,283 | 2.36 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 17 September 2026, the short share of BSX volume is 42.9%, up 1.5 points over the last five sessions. Over the last 52 readings it ranged from 19.2% (11 September 2026) to 72.0% (17 August 2026). The latest reading is 3.3 points below the 30-session average of 46.2%, on 12.4M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-17 | 5.3M | 12.4M | 42.9% | 49,947 |
| 2026-09-16 | 2.6M | 5.6M | 47.4% | 5,022 |
| 2026-09-15 | 3.2M | 7.8M | 41.4% | 13,649 |
| 2026-09-14 | 2.5M | 7.7M | 32.4% | 10,277 |
| 2026-09-11 | 2.3M | 11.9M | 19.2% | 2,293 |
| 2026-09-10 | 4.3M | 10.3M | 41.4% | 25,236 |
| 2026-09-09 | 2.9M | 6.5M | 44.9% | 417 |
| 2026-09-08 | 5.2M | 12.1M | 43.2% | 2,933 |
| 2026-09-04 | 2.5M | 6.7M | 37.8% | 48,702 |
| 2026-09-03 | 3.2M | 6.9M | 46.0% | 2,104 |
| 2026-09-02 | 2.6M | 6.7M | 38.6% | 8,543 |
| 2026-09-01 | 1.9M | 4.1M | 45.5% | 5,044 |
| 2026-08-31 | 3.3M | 6.3M | 52.7% | 3,708 |
| 2026-08-28 | 3.3M | 6.0M | 54.3% | 9,135 |
| 2026-08-27 | 3.6M | 7.0M | 50.7% | 16,020 |
| 2026-08-26 | 5.3M | 15.0M | 35.5% | 14,310 |
| 2026-08-25 | 3.4M | 6.9M | 49.9% | 30,538 |
| 2026-08-24 | 2.5M | 5.2M | 48.6% | 13,340 |
| 2026-08-21 | 3.2M | 6.0M | 53.6% | 4,422 |
| 2026-08-20 | 3.1M | 9.6M | 32.6% | 9,487 |
| 2026-08-19 | 4.4M | 7.9M | 55.1% | 6,957 |
| 2026-08-18 | 2.4M | 4.6M | 51.6% | 13,043 |
| 2026-08-17 | 4.8M | 6.7M | 72.0% | 447 |
| 2026-08-14 | 3.8M | 6.7M | 56.2% | 3,950 |
| 2026-08-13 | 3.5M | 5.4M | 64.7% | 6,444 |
| 2026-08-12 | 5.3M | 8.4M | 63.3% | 23,491 |
| 2026-08-11 | 2.9M | 6.5M | 43.7% | 4,640 |
| 2026-08-10 | 3.5M | 9.9M | 35.4% | 6,247 |
| 2026-08-07 | 2.1M | 4.3M | 48.2% | 2,195 |
| 2026-08-06 | 3.5M | 9.5M | 37.0% | 3,607 |
Fails to deliver
SEC, by settlement date. JSONAs of 24 August 2026, the fails-to-deliver balance in BSX is 3,497 shares, down 25,393 shares over the last settlement date. Over the last 52 readings it ranged from 1 share (5 February 2026) to 177,348 shares (1 May 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-24 | 3,497 | $50.37 | $176K |
| 2026-08-20 | 28,890 | $52.01 | $1.5M |
| 2026-08-12 | 51 | $51.19 | $3K |
| 2026-08-10 | 100 | $49.31 | $5K |
| 2026-08-04 | 1 | $48.43 | $48 |
| 2026-08-03 | 200 | $46.73 | $9K |
| 2026-07-29 | 11,681 | $46.06 | $538K |
| 2026-07-20 | 273 | $44.03 | $12K |
| 2026-07-15 | 38 | $42.63 | $2K |
| 2026-07-06 | 13,769 | $45.14 | $622K |
| 2026-07-02 | 2,224 | $43.06 | $96K |
| 2026-07-01 | 35,826 | $42.68 | $1.5M |
| 2026-06-30 | 14,456 | $43.48 | $629K |
| 2026-06-24 | 44 | $45.60 | $2K |
| 2026-06-22 | 1,381 | $45.29 | $63K |
| 2026-06-18 | 76,793 | $44.95 | $3.5M |
| 2026-06-15 | 72 | $46.91 | $3K |
| 2026-06-12 | 21 | $47.17 | $991 |
| 2026-06-11 | 520 | $48.34 | $25K |
| 2026-06-08 | 37,159 | $48.55 | $1.8M |
| 2026-06-05 | 211 | $48.85 | $10K |
| 2026-06-01 | 60,956 | $48.31 | $2.9M |
| 2026-05-29 | 12,003 | $49.11 | $589K |
| 2026-05-26 | 100 | $57.78 | $6K |
| 2026-05-22 | 26 | $57.15 | $1K |
| 2026-05-18 | 40 | $52.68 | $2K |
| 2026-05-14 | 9 | $53.06 | $478 |
| 2026-05-13 | 21,439 | $54.10 | $1.2M |
| 2026-05-08 | 8,866 | $56.57 | $502K |
| 2026-05-05 | 39,690 | $56.85 | $2.3M |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at BSX reported 6 open-market buys worth $9.5M in the last 90 days and no open-market sells. Clustered voluntary buying is historically the stronger insider signal because insiders buy for one reason. Latest filing: O'Connor Padraig Andrew (EVP, Global Operations) on 2026-09-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | O'Connor Padraig Andrew | EVP, Global Operations | Tax withholding | 567 | $48.37 | $27K | 8K |
| 2026-09-02 | O'Connor Padraig Andrew | EVP, Global Operations | Option exercise | 1K | $0.00 | $0 | 8K |
| 2026-08-25 | Morano Susan E | n/a | Buy | 2K | $49.22 | $100K | 14K |
| 2026-08-11 | Woodworth Emily | SVP, Global Controller and CAO | I | 3K | $51.19 | $150K | 3K |
| 2026-08-10 | Monson Jonathan | EVP and CFO | I | 10K | $50.46 | $500K | 10K |
| 2026-08-05 | Habiger David C | n/a | Buy | 2K | $47.59 | $100K | 17K |
| 2026-08-04 | Habiger David C | n/a | Buy | 140 | $48.59 | $7K | 15K |
| 2026-08-03 | Habiger David C | n/a | Buy | 1K | $48.07 | $50K | 15K |
| 2026-08-03 | Mahoney Michael F | Chairman, President & CEO | I | 22K | $48.43 | $1.1M | 22K |
| 2026-08-03 | Mahoney Michael F | Chairman, President & CEO | Buy | 186K | $48.33 | $9.0M | 1.6M |
| 2026-07-31 | LUDWIG EDWARD J | n/a | Buy | 5K | $45.48 | $227K | 30K |
| 2026-07-31 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | I | 64K | $46.73 | $3.0M | 64K |
| 2026-05-28 | Mahoney Michael F | Chairman, President & CEO | Gift | 387K | $0.00 | $0 | 0 |
| 2026-05-20 | Pegus Cheryl | n/a | Buy | 2K | $56.49 | $100K | 2K |
| 2026-05-20 | LUDWIG EDWARD J | n/a | Buy | 4K | $56.68 | $203K | 25K |
| 2026-05-20 | Habiger David C | n/a | Buy | 2K | $55.92 | $126K | 14K |
| 2026-05-19 | Habiger David C | n/a | Buy | 2K | $56.95 | $125K | 12K |
| 2026-05-07 | Zane Ellen M | n/a | Grant | 4K | $0.00 | $0 | 28K |
| 2026-05-07 | WICHMANN DAVID S | n/a | Grant | 4K | $0.00 | $0 | 45K |
| 2026-05-07 | Weber Christophe Pierre | n/a | Grant | 1K | $0.00 | $0 | 4K |
| 2026-05-07 | Weber Christophe Pierre | n/a | Grant | 2K | $0.00 | $0 | 3K |
| 2026-05-07 | Morano Susan E | n/a | Grant | 1K | $0.00 | $0 | 12K |
| 2026-05-07 | Morano Susan E | n/a | Grant | 4K | $0.00 | $0 | 10K |
| 2026-05-07 | Mega Jessica L | n/a | Grant | 4K | $0.00 | $0 | 12K |
| 2026-05-07 | LUDWIG EDWARD J | n/a | Grant | 4K | $0.00 | $0 | 22K |
| 2026-05-07 | Habiger David C | n/a | Grant | 4K | $0.00 | $0 | 9K |
| 2026-05-02 | O'Connor Padraig Andrew | EVP, Global Operations | Tax withholding | 872 | $56.50 | $49K | 7K |
| 2026-05-02 | O'Connor Padraig Andrew | EVP, Global Operations | Option exercise | 2K | $0.00 | $0 | 8K |
| 2026-05-02 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Tax withholding | 1K | $56.50 | $57K | 57K |
| 2026-05-02 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Option exercise | 2K | $0.00 | $0 | 58K |
| 2026-03-02 | Morano Susan E | n/a | Grant | 24 | $0.00 | $0 | 7K |
| 2026-03-02 | Weber Christophe Pierre | n/a | Grant | 323 | $0.00 | $0 | 879 |
| 2026-03-02 | Weber Christophe Pierre | n/a | Grant | 556 | $0.00 | $0 | 556 |
| 2026-03-01 | Woodworth Emily | SVP, Global Controller and CAO | Tax withholding | 372 | $76.85 | $29K | 3K |
| 2026-03-01 | Woodworth Emily | SVP, Global Controller and CAO | Option exercise | 838 | $0.00 | $0 | 3K |
| 2026-02-19 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | I | 7K | $75.76 | $519K | 20K |
| 2026-02-16 | Woodworth Emily | SVP, Global Controller and CAO | Tax withholding | 283 | $74.73 | $21K | 2K |
| 2026-02-16 | Woodworth Emily | SVP, Global Controller and CAO | Option exercise | 637 | $0.00 | $0 | 3K |
| 2026-02-16 | O'Sullivan Miriam | SVP, Chief HR Officer | Tax withholding | 291 | $74.73 | $22K | 17K |
| 2026-02-16 | O'Sullivan Miriam | SVP, Chief HR Officer | Option exercise | 990 | $0.00 | $0 | 18K |
| 2026-02-16 | O'Connor Padraig Andrew | EVP, Global Operations | Tax withholding | 339 | $74.73 | $25K | 6K |
| 2026-02-16 | O'Connor Padraig Andrew | EVP, Global Operations | Option exercise | 905 | $0.00 | $0 | 6K |
| 2026-02-16 | Monson Jonathan | EVP and CFO | Tax withholding | 440 | $74.73 | $33K | 38K |
| 2026-02-16 | Monson Jonathan | EVP and CFO | Option exercise | 990 | $0.00 | $0 | 38K |
| 2026-02-16 | Mahoney Michael F | Chairman, President & CEO | Tax withholding | 8K | $74.73 | $588K | 1.6M |
| 2026-02-16 | Mahoney Michael F | Chairman, President & CEO | Option exercise | 16K | $0.00 | $0 | 1.6M |
| 2026-02-16 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Tax withholding | 2K | $74.73 | $135K | 214K |
| 2026-02-16 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Option exercise | 4K | $0.00 | $0 | 216K |
| 2026-02-16 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Tax withholding | 1K | $74.73 | $92K | 56K |
| 2026-02-16 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Option exercise | 3K | $0.00 | $0 | 57K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON7 Form 144 notices on file for BSX worth $28.3M at the prices reported; 0 in the last 90 days worth $0. Latest: MICHAEL F MAHONEY filed on 2026-02-02 to sell 160,901 shares ($15.0M) from 2026-02-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-02-02 | MICHAEL F MAHONEYOfficer, Director | 161K | $15.0M | 0.011% | 2026-02-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-01 | ARTHUR C BUTCHEROfficer | 17K | $1.8M | 0.001% | 2025-12-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-06 | Zane Ellen MDirector | 3K | $284K | 0.000% | 2025-11-06 | Wells Fargo Clearing Services |
| 2025-11-03 | JOSEPH M FITZGERALDOfficer | 50K | $5.0M | 0.003% | 2025-11-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-28 | Zane Ellen MDirector | 3K | $297K | 0.000% | 2025-10-28 | Wells Fargo Clearing Services |
| 2025-10-27 | Zane Ellen MDirector | 10K | $1.0M | 0.001% | 2025-10-27 | Wells Fargo Clearing Services |
| 2025-10-01 | JOSEPH M FITZGERALDOfficer | 50K | $4.9M | 0.003% | 2025-10-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON4 holders above 5% have filed on BSX, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 7.5% of the class (111,127,205 shares), filed 2026-04-29 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-06 | 13G/Ano. 6 | FMR LLCparent holding company | 46.4M | 3.1% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 6 | Abigail P. Johnsonindividual | 46.4M | 3.1% | 2026-06-30 |
| 2026-05-06 | 13G/Ano. 5 | FMR LLCparent holding company | 75.8M | 5.1% | 2026-03-31 |
| 2026-05-06 | 13G/Ano. 5 | Abigail P. Johnsonindividual | 75.8M | 5.1% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 111.1M | 7.5% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 11 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding BSX at their latest 13F. JSON9 of the 30 tracked managers held BSX at their latest 13F, $3.24B in total at quarter-end prices. D. E. Shaw & Co. is the largest at $1.16B (0.6% of its portfolio) as of 2026-06-30. Over the prior quarter 6 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| D. E. Shaw & Co. | 2026-06-30 | 27.3M | $1.16B | 0.55% | +2.8M |
| Two Sigma Investments | 2026-06-30 | 19.4M | $828.9M | 0.60% | +10.0M |
| Citadel Advisors | 2026-06-30 | 10.2M | $433.4M | 0.05% | +3.4M |
| AQR Capital Management | 2026-06-30 | 9.7M | $413.2M | 0.14% | +4.4M |
| Millennium Management | 2026-06-30 | 5.9M | $232.1M | 0.08% | +603K |
| Renaissance Technologies | 2026-06-30 | 2.4M | $102.9M | 0.14% | -740K |
| Point72 Asset Management | 2026-06-30 | 877K | $37.4M | 0.04% | -5.0M |
| Bridgewater Associates | 2026-06-30 | 442K | $18.9M | 0.08% | +365K |
| Fisher Asset Management | 2026-06-30 | 334K | $14.2M | 0.00% | -117K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) BOSTON SCIENTIFIC CORP reported revenue of $5.44B, up 7.5% from the same quarter a year earlier (0.61 diluted EPS). In FY 2025 it generated $4.53B of operating cash flow. As of 2026-06-30, cash was $539.0M against $1.71B of debt.
- Cash
- $539.0M
- Debt
- $1.71B
- Equity
- $24.93B
- Total assets
- $45.22B
- Shares outstanding
- 1,449,229,526
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.44B | n/a | n/a | 0.61 |
| Q1 2026 | 2026-03-31 | $5.20B | n/a | n/a | 0.90 |
| Q4 2025derived | 2025-12-31 | $5.29B | n/a | n/a | n/a |
| Q3 2025 | 2025-09-30 | $5.07B | n/a | n/a | 0.51 |
| Q2 2025 | 2025-06-30 | $5.06B | n/a | n/a | 0.53 |
| Q1 2025 | 2025-03-31 | $4.66B | n/a | n/a | 0.45 |
| Q4 2024derived | 2024-12-31 | $4.56B | n/a | n/a | n/a |
| Q3 2024 | 2024-09-30 | $4.21B | n/a | n/a | 0.32 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $20.07B | n/a | $4.53B | $876.0M | n/a | n/a |
| FY 2024 | 2024-12-31 | $16.75B | n/a | $3.44B | $790.0M | n/a | $0 |
| FY 2023 | 2023-12-31 | $14.24B | n/a | $2.50B | $711.0M | n/a | $28.0M |
| FY 2022 | 2022-12-31 | $12.68B | n/a | $1.53B | $588.0M | $0 | $55.0M |
| FY 2021 | 2021-12-31 | $11.89B | n/a | $1.87B | $554.0M | $0 | $55.0M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-30 from the cover page.
What this page is
BOSTON SCIENTIFIC CORP in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows BOSTON SCIENTIFIC CORP (BSX), SEC CIK 885725, listed on NYSE, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-24.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-02-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-06.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-07-29.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 885725Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
- TNDMTANDEM DIABETES CARE INC
- DXCMDEXCOM INC
- PENPenumbra Inc
- SIBNSI-BONE, Inc.
- MMM3M CO
- LMATLEMAITRE VASCULAR INC
- INSPInspire Medical Systems, Inc.
- NVCRNovoCure Ltd
- RMDRESMED INC
- SYKSTRYKER CORP
- GKOSGLAUKOS Corp
- IRTCiRhythm Holdings, Inc.
- ICUIICU MEDICAL INC/DE
- ATECAlphatec Holdings, Inc.
- AORTARTIVION, INC.
- PODDINSULET CORP
- BDXBECTON DICKINSON & CO
- IRMDIRADIMED CORP
- ATRCAtriCure, Inc.
- UFPTUFP TECHNOLOGIES INC
- LUNGPulmonx Corp
- MMSIMERIT MEDICAL SYSTEMS INC
- ANGOANGIODYNAMICS INC
- OFIXOrthofix Medical Inc.
Datasets
Frequently Asked Questions
How much of BSX is sold short?
What is BSX's daily short volume?
Does BSX have fails to deliver?
Are BSX insiders buying or selling?
Have BSX insiders filed to sell?
Who owns more than 5% of BSX?
What did BSX report last quarter?
Which funds hold BSX?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.